Total Payments
$1,068
2024 Payments
$20.92
Companies
13
Transactions
60
Medicare Patients
1,370
Medicare Billing
$74,719
Payment Breakdown by Category
Food & Beverage$1,068 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,068 | 60 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $210.78 | 10 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $185.71 | 12 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $162.26 | 9 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $139.52 | 8 | $0 (2023) |
| ABBVIE INC. | $92.03 | 5 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $86.63 | 4 | $0 (2022) |
| Avanir Pharmaceuticals, Inc. | $38.72 | 2 | $0 (2021) |
| Melinta Therapeutics, LLC | $35.87 | 2 | $0 (2021) |
| Scilex Pharmaceuticals Inc. | $29.73 | 2 | $0 (2022) |
| Lilly USA, LLC | $27.75 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20.92 | 1 | Pharmacosmos Therapeutics Inc. ($20.92) |
| 2023 | $101.87 | 6 | AstraZeneca Pharmaceuticals LP ($38.06) |
| 2022 | $461.45 | 26 | Bayer HealthCare Pharmaceuticals Inc. ($128.52) |
| 2021 | $484.07 | 27 | AstraZeneca Pharmaceuticals LP ($113.76) |
All Payment Transactions
60 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: HEMATOLOGY | ||||||
| 04/11/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/02/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Cardio-renal | ||||||
| 02/27/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: RESPIRATORY | ||||||
| 02/08/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/23/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/19/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Cardio-renal | ||||||
| 12/13/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Cardio-renal | ||||||
| 12/07/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Gastroenterology | ||||||
| 12/01/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/21/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Cardio-renal | ||||||
| 10/06/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: NEUROSCIENCE | ||||||
| 09/22/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Cardio-renal | ||||||
| 08/25/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/10/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/02/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Diabetes | ||||||
| 08/01/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Cardio-renal | ||||||
| 07/11/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Diabetes | ||||||
| 06/29/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: Gastroenterology | ||||||
| 06/09/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Cardio-renal | ||||||
| 05/27/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Diabetes | ||||||
| 05/17/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/11/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Inflammation | ||||||
| 05/10/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 250 | 289 | $46,646 | $14,697 |
| 2022 | 12 | 351 | 450 | $27,244 | $14,100 |
| 2021 | 12 | 471 | 562 | $32,416 | $17,700 |
| 2020 | 3 | 298 | 303 | $312,584 | $28,223 |
Total Patients
1,370
Total Services
1,604
Medicare Billing
$74,719
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 103 | 118 | $25,230 | $7,362 | 29.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 109 | 132 | $16,586 | $5,162 | 31.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 19 | 19 | $4,690 | $2,036 | 43.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 19 | 20 | $140.00 | $137.20 | 98.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 112 | 174 | $16,530 | $8,244 | 49.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 13 | 13 | $1,950 | $1,367 | 70.1% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 32 | 35 | $1,925 | $1,111 | 57.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 33 | 33 | $990.00 | $876.64 | 88.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 12 | 12 | $900.00 | $822.48 | 91.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 18 | $1,530 | $541.77 | 35.4% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 22 | 22 | $1,100 | $440.80 | 40.1% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 19 | 22 | $620.00 | $260.17 | 42.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 52 | 61 | $427.00 | $180.30 | 42.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 15 | 21 | $735.00 | $173.39 | 23.6% |
| 81002 | Urinalysis, manual test | Office | 2022 | 15 | 16 | $192.00 | $54.90 | 28.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 13 | 23 | $345.00 | $26.52 | 7.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 127 | 195 | $18,525 | $9,808 | 52.9% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 81 | 81 | $3,680 | $2,907 | 79.0% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 27 | 27 | $1,215 | $1,005 | 82.7% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 29 | 29 | $1,275 | $849.92 | 66.7% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 25 | 27 | $1,485 | $812.59 | 54.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 22 | 25 | $2,125 | $788.51 | 37.1% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 25 | 25 | $1,250 | $492.72 | 39.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 31 | 31 | $930.00 | $491.66 | 52.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 19 | 28 | $980.00 | $229.50 | 23.4% |
About Shellie Ray, NP
Shellie Ray, NP is a Family healthcare provider based in Oxford, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2013. The National Provider Identifier (NPI) number assigned to this provider is 1891136636.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Shellie Ray, NP has received a total of $1,068 in payments from pharmaceutical and medical device companies, with $20.92 received in 2024. These payments were reported across 60 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,068).
As a Medicare-enrolled provider, Ray has provided services to 1,370 Medicare beneficiaries, totaling 1,604 services with total Medicare billing of $74,719. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Nurse Practitioner
- Location Oxford, MA
- Active Since 07/09/2013
- Last Updated 04/11/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1891136636
Products in Payments
- FARXIGA (Drug) $174.34
- Kerendia (Drug) $162.26
- ENTRESTO (Drug) $119.52
- Rybelsus (Drug) $97.08
- XIFAXAN (Drug) $86.63
- Ozempic (Drug) $66.72
- UBRELVY (Drug) $47.31
- RYBELSUS (Drug) $46.98
- VRAYLAR (Drug) $44.72
- Kimyrsa (Drug) $35.87
- TRELEGY ELLIPTA (Drug) $25.30
- Nuedexta (Drug) $22.43
- MONOFERRIC (Drug) $20.92
- LEQVIO (Drug) $20.00
- NUEDEXTA (Drug) $16.29
- TRULICITY (Drug) $13.93
- EMGALITY (Drug) $13.82
- Otezla (Drug) $13.09
- BREZTRI (Drug) $11.37
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Oxford
Shannon Fryery, Np, NP
Family — Payments: $75,699
Family $75,699
Mrs. Penny Burcham, Cfnp, CFNP
Family — Payments: $17,211
Family $17,211
Ms. Dorionne Whitaker, Cnp, CNP
Family — Payments: $14,626
Family $14,626
Anna Wiygul, Fnp-Bc, FNP-BC
Family — Payments: $11,405
Family $11,405
Erin Smith, Nurse Practitioner, NURSE PRACTITIONER
Family — Payments: $9,981
Family $9,981
Brandi Meads, Crnp, CRNP
Family — Payments: $8,920
Family $8,920